Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Online Platform Aims to Empower and Unite Sickle Cell Disease Community; oneSCDvoice.com Pre-Registration Now Open
  • USA - English


News provided by

rareLife solutions

Nov 29, 2017, 16:25 ET

Share this article

Share toX

Share this article

Share toX

oneSCDvoice
oneSCDvoice
Youtube
Youtube

SOUTH NORWALK, Conn. (PRWEB) November 29, 2017 -- People affected by the devastating genetic condition sickle cell disease (SCD) will be able to have free access to a robust support and knowledge network when oneSCDvoice.com launches in December, rareLife solutions, creators of the “onevoice” platform system, announced today.

'an empowering online community' created by a unique collaboration between sickle cell healthcare providers and advocacy leaders, Pfizer, Inc. and health technology company, rareLife solutions.

Post this

SCD patients, their family members, caregivers, and advocates may pre-register now at http://www.oneSCDvoice.com to join what its organizers describe as “an empowering online community” created by a unique collaboration between sickle cell healthcare providers and advocacy leaders, Pfizer, Inc. and health technology company, rareLife solutions. “This collaborative digital education platform provides professionally vetted links to credible information about SCD,” Dan Donovan, Co-Founder & CEO of rareLife said. “Specifically, this information will help patients increase their knowledge of the disease, lifestyle issues and help demystify clinical trials.”

SCD is a disorder primarily affecting men and women of African descent, but also those of Latino, Arab or Indian ancestry: in the U.S., approximately one of every 12 African-Americans carries the SCD gene, with as many as 100,000 currently living with the disease, according to the Sickle Cell Disease Association of America.

Collaborating Drives Digital Community Support & Education Platform

oneSCDvoice – promoted as “A Sickle Cell Community Tailored to You” – is exclusively geared toward helping people impacted by SCD, Donovan explained. “We built this platform after seeking and receiving SCD community input with regard to their particular needs as voiced by them,” he said.

“So far, our collaboration has brought together more than 25 active and passionate SCD medical and advocacy advisors, Pfizer Rare Disease and our own team at rareLife. The community advisors are providing invaluable insights on elements such as subjects, topics, sources, language – even the platform's colors and graphics. It really becomes ‘their home’ online for SCD. The Clinical Trial Education section, which provides valuable resources to educate on topics such as diversity, safety, and participation in clinical trials, was the result of efforts led by Pfizer, who has deep expertise in this area," said Donovan.

SCD community collaborators for oneSCDvoice include individuals from the Sickle Cell Disease Association of America, the International Association of Sickle Cell Nurses and Professional Associates, the William E. Proudford Sickle Cell Fund, Inc., Sickle Cell Disease Association of Illinois, Sickle Cell 101, SikCell, #boldlipsforsicklecell, The Martin Center Sickle Cell Initiative, The Foundation for Sickle Cell Disease Reasearch Foundation, Sickle Cell Support Services, Sickle Cell Community Consortium, sickle cell medical and scientific experts, and well-respected advocates and social media leaders. rareLife welcomes additional advocacy collaborators.

oneSCDvoice is Like Having Your Own "Cybrarian"

T Anthony Howell, Co-Founder and rareLife solutions’ COO, revealed that oneSCDvoice provides a unique education feature that inserts trusted links directly into conversations – like a librarian who hands a student a resource.

“Our community advisors create a library of Trusted Resources that houses thousands of links to SCD medical information, research, patient advocates, care providers, organizations, news, community activities, and more. In addition, oneSCDvoice provides a SMART Social Wall where community-driven conversations occur,” Howell said.

“The unique feature is that our software - we call it the ‘cybrarian’ - analyzes the posts, goes into the Trusted Resources to find vetted content relevant to the posted topics, and then inserts great videos, experts, news articles, etc. directly into the conversation – at the point when people are talking about it and receptive to learn more.”

The FDA Prioritizes the “Patient Voice”

With passage of the 21st Century Cures Act, the federal Food & Drug Administration is mandated to create a framework by which patients can be heard. Now, in addition to traditional clinical trial data collected through human trials, the FDA can consider other information to help guide regulators in their assessments of new treatments.

“The availability of patient experience data from a trackable longitudinal cohort of patients,” Howell said. “Will enable rareLife researchers to provide insights to the community in the form of infographics and other educational tools – which help create an engaged and learned membership.”

oneSCDvoice Benefits the SCD Community

A longstanding difficulty faced by those living with SCD has been the availability of reliable SCD information, Howell asserted.

“oneSCDvoice represents a solution to this situation,” he said. “We’ve been collaborating with the SCD community’s leaders in medicine and advocacy and using advanced-degree researchers to find the best information and then link to it – we’re an ‘amplification’ site that does not compete with the existing community. We take the best of what they have created and by attaching a social community to the resources they seek, we expect lasting engagement.”

oneSCDvoice is also expected to help diminish the isolation and stigma SCD patients experience. “Patients and advocates told us that there is a stigma associated with SCD, of ‘being different,’” Howell said. “oneSCDvoice will allow neutral, knowledgeable, and diplomatic Community Managers who are trained to make sure nobody who engages with this platform takes his or her journey alone.”

For more information, contact Rich Smith by email at rich(at)newsdesk365.com. To sign up for no-cost access to oneSCDvoice – go to http://www.oneSCDvoice.com.

About rareLife solutions

Founded 2013, rareLife solutions is the health tech, design and research team behind oneSCDvoice, the onevoice modular community system, and additional customized rare disease platforms. rareLife solutions offers integrated strategic and tactical community engagement plans, medical communications and publication planning consulting services and collaborative platform as a service (PaaS) solutions for advocacy groups, pharmaceutical and device companies, medical and research centers, contract research organizations and professional healthcare associations. To learn more, please visit us at http://www.rareLifesolutions.com and http://www.onevoice.world, follow us on Twitter at @rareLifeTalks and @onevoiceworld, join us on LinkedIn, and like us on Facebook at Facebook.com/rareLifeSolutions and Facebook.com/onevoiceworld.

Rich Smith, rareLife solutions, http://www.rarelifesolutions.com, +1 2092453362, rich@newsdesk365.com

Modal title

In the Internet We Trust
View PDF
In the Internet We Trust
When the Orphan Patient Speaks, Listen
View PDF
When the Orphan Patient Speaks, Listen
Clinical Trial Education Center
Clinical Trial Education Center
SMART Social Wall
SMART Social Wall
Interactive LinkWheel
Interactive LinkWheel
In the Internet We Trust When the Orphan Patient Speaks, Listen Clinical Trial Education Center SMART Social Wall Interactive LinkWheel

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.